KLRK1 and metabolic dysfunction-associated steatohepatitis: Kahraman et al. have reported that patients with NALFD have decreased numbers of liver NK cells, while those with NASH exhibit high NKG2D expression in the liver parenchyma, which is associated with increased liver NK cells with elevated gene and protein expression of its ligand, major histocompatibility complex class I–related chains A/B.50